GR Trademark

Trademark Overview

On Friday, July 12, 2002, a trademark application was filed for GR with the United States Patent and Trademark Office. The USPTO has given the GR trademark a serial number of 78143547. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 14, 2013. This trademark is owned by DepoMed, Inc.. The GR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents

General Information

Serial Number78143547
Word MarkGR
Filing DateFriday, July 12, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 14, 2013
Registration Number3169289
Registration DateTuesday, November 7, 2006
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 10, 2003

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 14, 2013
Primary Code005
First Use Anywhere DateWednesday, August 30, 2006
First Use In Commerce DateWednesday, August 30, 2006

Trademark Owner History

Party NameDepoMed, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560
Party NameDepoMed, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NameDepoMed, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Friday, June 14, 2013CANCELLED SEC. 8 (6-YR)
Saturday, February 16, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, February 16, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 15, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 15, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 7, 2006REGISTERED-PRINCIPAL REGISTER
Friday, September 29, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, September 29, 2006ASSIGNED TO LIE
Tuesday, September 26, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 25, 2006STATEMENT OF USE PROCESSING COMPLETE
Friday, September 1, 2006USE AMENDMENT FILED
Friday, September 1, 2006TEAS STATEMENT OF USE RECEIVED
Friday, February 17, 2006EXTENSION 5 GRANTED
Friday, February 17, 2006EXTENSION 5 FILED
Friday, February 17, 2006TEAS EXTENSION RECEIVED
Thursday, August 18, 2005EXTENSION 4 GRANTED
Thursday, August 18, 2005EXTENSION 4 FILED
Thursday, August 18, 2005TEAS EXTENSION RECEIVED
Saturday, March 26, 2005EXTENSION 3 GRANTED
Tuesday, March 1, 2005EXTENSION 3 FILED
Tuesday, March 1, 2005TEAS EXTENSION RECEIVED
Friday, September 10, 2004EXTENSION 2 GRANTED
Tuesday, August 31, 2004EXTENSION 2 FILED
Tuesday, August 31, 2004TEAS EXTENSION RECEIVED
Friday, August 20, 2004CASE FILE IN TICRS
Friday, March 5, 2004EXTENSION 1 GRANTED
Wednesday, February 25, 2004EXTENSION 1 FILED
Wednesday, February 25, 2004TEAS EXTENSION RECEIVED
Tuesday, September 2, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 10, 2003PUBLISHED FOR OPPOSITION
Wednesday, May 21, 2003NOTICE OF PUBLICATION
Thursday, April 10, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 10, 2003EXAMINERS AMENDMENT E-MAILED
Thursday, April 10, 2003ASSIGNED TO EXAMINER
Tuesday, November 19, 2002NON-FINAL ACTION MAILED
Wednesday, November 6, 2002ASSIGNED TO EXAMINER

Related Keywords

release continuous tablets wide variety agents therapeutic oral based drug